maple syrup urine disease

(redirected from maple syrup urine)
Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to maple syrup urine: alkaptonuria, homocystinuria, MSUD

maple syrup urine disease

 
a genetic disorder involving deficiency of an enzyme necessary in the metabolism of branched-chain amino acids, marked clinically by mental and physical retardation, feeding difficulties, and a characteristic odor of the urine.

ma·ple syr·up u·rine dis·ease

[MIM*248600]
an inborn error of metabolism caused by defective oxidative decarboxylation of α-keto acids of leucine, isoleucine, and valine; these branched-chain amino acids are present in the blood and urine in high concentrations; manifestations of disease include feeding difficulties, physical and mental retardation, and a urine odor similar to that of maple syrup; neonatal death is common. Autosomal recessive inheritance, caused by mutation in the E1, E2 or E3 subunit of the branched-chain α-keto acid dehydrogenase gene (BCKDH) on 19q. There are various forms differentiated by the subunit of BCKDH mutated.
A rare autosomal recessive [MIM 248600] inborn error of metabolism due to decreased branched-chain -keto acid dehydrogenase complex activity, resulting in defective amino acid metabolism, characterised by urine that smells like maple syrup
Frequency General population 1:200,000; in Pennsylvania Mennonites of German descent 1:176
Pathogenesis The defect in oxidative decarboxylation of branched chain amino acids—BCAA—valine, leucine and isoleucine results in accumulation of BCAA
Lab Increased BCAA, decreased threonine, serine, alanine in urine and serum, positive dinitro-phenylhydrazine test for alpha-keto amino acids, which form insoluble hydrazines
Management Dietary decrease of BCAA, plus dietary overload—20-fold excess of thiamine
Prognosis Mortality was 100%, often due to intercurrent infection; with BCAA-free infant formulas, the survival is ±100% and mental retardation completely preventable; since acute decompensation by BCAA and BCKA is due to a breakdown of endogenous proteins resulting in metabolic acidosis, ketosis, anorexia, emesis and potentially fatal encephalopathy, patients may respond to parenteral solutions of BCAA-free amino acids

maple syrup urine disease

Branched chain ketoaciduria Neonatology A rare AR inborn error of metabolism due to ↓ branched-chain α-keto acid dehydrogenase complex activity, resulting in defective amino acid metabolism, characterized by urine that smells like maple syrup Frequency General population 1:200,000; in Pennsylvania Mennonites of German descent 1:176; the defect in oxidative decarboxylation of branched chain amino acids–BCAA, valine, leucine and isoleucine results in accumulation of BCAA Clinical Neonatal onset, ↓ Moro reflex, dyspnea, spasticity, opisthotonos, mental and growth retardation, severe hypotonia, feeding difficulties, hypoglycemia, convulsions, decorticate rigidity Lab ↑ BCAA, ↓ threonine, serine, alanine in urine and serum, a positive dinitro-phenylhydrazine test for α keto amino acids, which form insoluble hydrazines Treatment Dietary ↓ of BCAA, plus dietary overload–20-fold excess of thiamine Prognosis Mortality was formerly 100%, often due to intercurrent infection; with BCAA-free infant formulas, the survival is virtually 100% and mental retardation completely preventable; since acute decompensation by BCAA and BCKA is due to a breakdown of endogenous proteins resulting in metabolic acidosis, ketosis, anorexia, emesis and potentially fatal encephalopathy, Pts may respond to parenteral solutions of BCAA-free amino acids

ma·ple syr·up u·rine dis·ease

(MSUD) (māpĕl sirŭp yūrin di-zēz)
Inborn error of metabolism caused by defective oxidative decarboxylation of α-keto acids of leucine, isoleucine, and valine; manifestations include feeding difficulties, physical and mental retardation, and a urine odor similar to that of maple syrup; neonatal death is common.

maple syrup urine disease

A hereditary defect of protein metabolism in which the breakdown of amino acids is defective because of the absence of an oxidase enzyme. The result is the presence of keto-acids with an odour of maple syrup in the urine. The condition causes serious neurological disturbances and death within a few months of birth.
References in periodicals archive ?
Maple syrup urine disease: dif fusion-weighted MRI findings during acute metabolic encephalopathic crisis.
Ekbote, "Isoleucine deficiency in a neonate treated for maple syrup urine disease masquerading as acrodermatitis enteropathica," Indian Pediatrics, vol.
Danner et al., "Thiamine response in maple syrup urine disease," Pediatric Research, vol.
Cognitive and adaptive functioning after liver transplantation for maple syrup urine disease: a case series.
Congenital lactic acidosis, alpha-ketoglutaric aciduria and variant form of maple syrup urine disease due to a single enzyme defect: dihydrolipoyl dehydrogenase deficiency.
Branched-chain ketoacidosis, better known as maple syrup urine disease (MSUD) or maple syrup disease (MSD), is often referred to in most pediatric textbooks, yet very rarely seen by most pediatric care providers.
Of these 8 tests, it is currently up to state public health agencies whether they also screen for maple syrup urine disease, homocystinuria, biotinidase deficiency, and congenital adrenal hyperplasia.
The sisters have a life-threatening metabolic problem, Maple Syrup Urine Disorder.
Based on our promising preclinical data, we plan to advance two Synthetic Biotic candidates into IND-enabling studies, broadening the platform's scope into immuno-oncology and adding an additional application in inborn errors of metabolism for the treatment of maple syrup urine disease."
The NHS Newborn Blood Spot Screening programme will be expanded to screen for homocystinuria (HCU), maple syrup urine disease (MSUD), glutaric aciduria type 1 (GA1) and isovaleric acidaemia (IVA).
At present, the NBS in the country includes screening of six disorders: congenital hypothyroidism, congenital adrenal hyperplasia, phenylketonuria, glucose-6-phosphate dehydrogenase deficiency, galactosemia and maple syrup urine disease.